Four Penn Medicine Studies Named Among Nation’s Top 10 Clinical Research Advances
The Clinical Research Forum’s Top 10 Clinical Research Achievement Awards honor outstanding accomplishments in clinical research.
Penn Medicine and CHOP Faculty Make the TIME100 Health List for CRISPR Gene Therapy Breakthrough
Two doctors were recognized by TIME as pioneers in healthcare for successfully treating KJ Muldoon.
Penn Received $7.8 Million from ARPA-H to Advance Lymphatic Imaging and AI-Driven Disease Detection
The project is led by Maxim Itkin, MD, Professor of Radiology at Penn Medicine and the director of Penn’s Center for Lymphatic Disorders.
Penn Expands its Immunology Research
Penn’s newly developed seven-story facility at 3600 Civic Center Boulevard will bring together labs across disciplines to advance breakthroughs in immune health, autoimmunity, and infectious diseases.
Dispatch Bio Developing Tumor-Agnostic Immunotherapy Targeting Solid Tumors
The technology, now in preclinical development, has the potential to overcome the limitations of traditional cancer treatments for solid tumors.
Opus Genetics Reports Positive Pediatric Data from its Clinical Trial Evaluating Investigational Gene Therapy for a Rare Eye Disorder
These findings suggest OPGx-LCA5, Opus Genetics' investigational gene augmentation therapy, could improve vision for patients previously considered untreatable.
GEMMA Biotherapeutic Announces Clinical Trial Authorization for New Gene Therapy Treatment
Its novel gene therapy for spinal muscular atrophy type 1 (SMA1) has been cleared for clinical trial in Brazil by ANVISA.
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel
Rese-cel is an experimental CAR T-cell therapy designed to “reset” the immune system in people with autoimmune diseases.
Avisi Technologies Announces First Patient Implanted with Glaucoma Treatment Device in Clinical Trial
Avisi treated its first patient in a clinical trial to evaluate the safety and effectiveness of its novel VisiPlate® glaucoma treatment device.
BlueWhale Bio Raises $5M, Partners with Avantor, Inc.
BlueWhale Bio was co-founded by Carl June, MD, the Richard W. Vague Professor in Immunotherapy and James Riley, PhD, Professor of Microbiology, both at Penn Medicine.